Industries > Pharma > RNA Analysis/Transcriptomics Market Report 2020-2030

RNA Analysis/Transcriptomics Market Report 2020-2030

Forecasts by Type (Microarrays, Polymerase Chain Reaction (PCR), Sequencing Technologies, RNAI Gene Silencing), by Application (Clinical Diagnosis, Drug Discovery, Toxicogenomic), by End-user (Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) PLUS Analysis of Leading Medical Device Contract Manufacturing Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 30 October 2020
PAGES: 466
PRODUCT CODE: PHA0973
SUBMARKET: Biotechnology

Clear
WOOCS 2.2.1
SKU: PHA0973 Categories: , Tag:

Demand for RNA Analysis/Transcriptomics Technologies
Increasing demand for personalised medicines by end users and manufacturers followed by technological advancement in the field of RNA analysis will open new avenues for the market in coming years. Hectic lifestyle followed by changing dietary habits in developed as well developing economies have increased prevalence of chronic diseases such as cancer and diabetes. All these factors will increase demand for RNA analysis/Transcriptomics technologies for drug development and discovery. However, the shortage of trained specialists coupled with challenges of handling sequencing data will be the key market restraining factors.

What are the Market Driving Factors?
• Increasing Technological Advancements in The Field of Omics Research
• Increasing Preference for Personalized Medicine

Key Challenges and Threats for RNA Analysis/Transcriptomics Market
• Shortage of Skilled Professionals
• Dearth of Effective Bioinformatics tools

What are the Market Opportunities?
• Transcriptomic Technologies in the Field of Drug and Biomarker Discovery
• Increasing R&D Spending of Biopharmaceutical Companies
• Investment, and Future Aspects of RNA Therapeutics

Leading companies and the potential for market growth
• The global RNA analysis/transcriptomics market is consolidated in nature as top 7 companies operating in this industry accounted for >40% of the overall market share.
• Key companies operating in this industry are Affymetrix Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., and Fluidigm Corporation.
• Prominent players operating in this industry are adopting mergers & acquisitions, new product development, technological advancement, and partnership strategies in order to gain competitive edge in this industry. For instance, in April 2020, Bio-Rad Laboratories acquired Celsee, a company engaged in offering instruments and consumables for single-cell analysis.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

To access the data contained in this document please email contactus@visiongain.com

Global RNA Analysis/Transcriptomics Market by Type
• Microarrays
• Polymerase Chain Reaction (PCR)
• Sequencing Technologies
• RNAI Gene Silencing

Global RNA Analysis/Transcriptomics Market by Application
• Clinical Diagnosis
• Drug Discovery
• Toxicogenomic

Global RNA Analysis/Transcriptomics Market by End User
• Academic Research & Government Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers

CTA

Global RNA Analysis/Transcriptomics Market by Region

• North America
• U.S.
• Canada

• Europe
• Germany
• UK
• France
• Rest of Europe

• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America

• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa

Need industry data? Please contact us today.

How the Global RNA Analysis/Transcriptomics Market report helps you?
• In addition to revenue forecasting to 2030, our new study provides you with recent market development and future aspects such as Next Generation Sequencing Technology, Biopharmaceutical R&D Expenditure, Technological Advancement in Omics Research
• Qualitative analyses such as market drivers, opportunities, restraints, challenges, SWOT analysis, Porter’s Five Forces model, company market share analysis, investment and future aspects of RNA therapeutics and commercial developments.
• Revenue forecasts to 2030 for Global RNA Analysis/Transcriptomics Market, with forecasts for Type, Application, and End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Additionally, the RNA Analysis/Transcriptomics Market study analyses vendor landscape using company profiles, revenues, business segment, and company market share analysis.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today RNA Analysis/Transcriptomics Market Report 2020-2030: Forecasts by Type (Microarrays, Polymerase Chain Reaction (PCR), Sequencing Technologies, RNAI Gene Silencing), by Application (Clinical Diagnosis, Drug Discovery, Toxicogenomic), by End-user (Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) PLUS Analysis of Leading Medical Device Contract Manufacturing Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for RNA Analysis/Transcriptomics Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for RNA Analysis/Transcriptomics Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

READ

Visiongain Publishes Antigen Skin Test Market Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.

12 January 2021

READ

Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.

11 January 2021

READ

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Categories

Category